Novartis Investigative Site

Karlstad 681 85

0 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Disease, Chronic Heart Failure, Heart Failure With Preserved Ejection Fraction, Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy, Hypertension, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early